Awarded
Vaccin nonavalent contre les infections à papillomavirus humain (types 6, 11, 16, 18, 31, 33, 45, 52 et 58)
Original language: French
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- MSD FRANCE
- Contract value
- no value published
- Bids received
- 1
- Published
- 25 Aug 2026
- Awarded
- 11 Aug 2026
- Contract start
- 11 Aug 2026
- Contract end
- 28 Aug 2027estimated
- Region
- Paris